Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Recher

Showing results (421-430 of 488) with videos related to

Pageof 49
Sort By:
American Journal of Hematology|January 22, 2013
Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patientsBruno Royer, Lavinia Merlusca, Julie Abraham, et al.
Blood|September 17, 2015
MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA studyChristiane Copie-Bergman, Peggy Cuillière-Dartigues, Maryse Baia, et al.
Transplantation and Cellular Therapy|December 16, 2022
Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage ChemotherapyAlexander E Perl, Richard A Larson, Nikolai A Podoltsev, et al.
Immunity|May 24, 2016
Memory CD8(+) T Cells Require Increased Concentrations of Acetate Induced by Stress for Optimal FunctionMaria L Balmer, Eric H Ma, Glenn R Bantug, et al.
Journal of Clinical Immunology|July 21, 2023
Immunologic and Genetic Contributors to CD46-Dependent Immune DysregulationBenedikt J Meyer, Natalia Kunz, Sayuri Seki, et al.
Journal for Immunotherapy of Cancer|February 22, 2019
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patientsMirjam Fässler, Stefan Diem, Joanna Mangana, et al.
Blood|December 19, 2009
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceLionel Adès, Agnes Guerci, Emmanuel Raffoux, et al.
Haematologica|June 1, 2023
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinibRuben Mesa, Srdan Verstovsek, Uwe Platzbecker, et al.
Blood|January 17, 2013
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemiaEric Jourdan, Nicolas Boissel, Sylvie Chevret, et al.
Cell Death and Differentiation|September 27, 2014
Toso regulates differentiation and activation of inflammatory dendritic cells during persistence-prone virus infectionP A Lang, A Meryk, A A Pandyra, et al.
Pageof 49

Showing results (421-430 of 488) with videos related to

Sort By:
Pageof 49
American Journal of Hematology|January 22, 2013
Efficacy of lenalidomide in POEMS syndrome: a retrospective study of 20 patientsBruno Royer, Lavinia Merlusca, Julie Abraham, et al.
Blood|September 17, 2015
MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA/LYSA studyChristiane Copie-Bergman, Peggy Cuillière-Dartigues, Maryse Baia, et al.
Transplantation and Cellular Therapy|December 16, 2022
Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage ChemotherapyAlexander E Perl, Richard A Larson, Nikolai A Podoltsev, et al.
Immunity|May 24, 2016
Memory CD8(+) T Cells Require Increased Concentrations of Acetate Induced by Stress for Optimal FunctionMaria L Balmer, Eric H Ma, Glenn R Bantug, et al.
Journal of Clinical Immunology|July 21, 2023
Immunologic and Genetic Contributors to CD46-Dependent Immune DysregulationBenedikt J Meyer, Natalia Kunz, Sayuri Seki, et al.
Journal for Immunotherapy of Cancer|February 22, 2019
Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patientsMirjam Fässler, Stefan Diem, Joanna Mangana, et al.
Blood|December 19, 2009
Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experienceLionel Adès, Agnes Guerci, Emmanuel Raffoux, et al.
Haematologica|June 1, 2023
Clinical outcomes of patients with myelofibrosis after immediate transition to momelotinib from ruxolitinibRuben Mesa, Srdan Verstovsek, Uwe Platzbecker, et al.
Blood|January 17, 2013
Prospective evaluation of gene mutations and minimal residual disease in patients with core binding factor acute myeloid leukemiaEric Jourdan, Nicolas Boissel, Sylvie Chevret, et al.
Cell Death and Differentiation|September 27, 2014
Toso regulates differentiation and activation of inflammatory dendritic cells during persistence-prone virus infectionP A Lang, A Meryk, A A Pandyra, et al.
Pageof 49